Ghasha ultra sour gas project : Lukoil acquires 5% stake from ADNOC

Russian energy company Lukoil has acquired a 5% stake in the Ghasha ultra sour gas project in the Arabian Gulf, offshore Abu Dhabi, from the Abu Dhabi National Oil Company (ADNOC). The Ghasha ultra sour gas project will involve the development of previously undeveloped deposits of gas, oil and gas condensate across nine shallow fields, […]

Denovo Biopharma gets FDA approval to launch phase 2b GBM trial for DB102

Denovo Biopharma has secured approval from the US Food and Drug Administration (FDA) to launch its phase 2b clinical trial of DB102 in patients with newly-diagnosed glioblastoma (GBM) in combination with radiation and temozolomide. The GBM clinical study is an extension of the company’s work to identify a genetically-enriched patient population with diffuse large B-cell […]

Pillsbury Baking launches Brownie Bark Mixes, Funfetti Cake Mixes and Frostings

Pillsbury Baking has launched new products in the US in the form of the Pillsbury Brownie Bark Mixes, Funfetti Galaxy Frosting, Funfetti Yellow Cake Mix, Funfetti Unicorn Frosting, and Funfetti Strawberry Cake Mix. Brownie Bark Mixes are thinner, flatter snacks and treats that help customers to bake fresh brownie bark at home. This thin sweet […]

DAZZLE clinical trial : Kodiak Sciences doses first patients with KSI-301 in phase 3 wet AMD trial

Kodiak Sciences said that it has treated the first patients in the phase 2 DAZZLE clinical trial of KSI-301, its investigational intravitreal anti-VEGF antibody biopolymer conjugate, in wet age-related macular degeneration (wet AMD). The DAZZLE trial (also called KSI-CL-102) is designed to assess the safety and efficacy of KSI-301 in AMD patients who are treatment-naïve. […]

Miyagi Osato Solar Park : Total breaks ground on Japanese solar power plant

Total Solar International, a subsidiary of French oil and gas giant Total has begun the construction of a 52MW solar power plant called Miyagi Osato Solar Park located in Osato in the Japanese prefecture Miyagi, as per the latest solar industry news.  The peaking solar power plant had secured financial close and is expected to […]

Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818

Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of CRL4-CRBN modulator KPG-818 in the US. KPG-818 is being developed for the treatment of systemic lupus erythematosus (SLE) or hematological malignancies. The single ascending dose (SAD) randomized, double-blind, placebo-controlled study assessed the safety, tolerability, and pharmacokinetics of […]

Radioisotopes manufacturer SHINE Medical Technologies creates pharma unit

US radioisotopes manufacturer SHINE Medical Technologies has formed a new business division called SHINE Therapeutics in a move to boost its ability to focus on addressing critical future needs in the therapeutic isotope market. SHINE Therapeutics will focus initially on developing and commercializing lutetium‑177 or Lu‑177, which is a therapeutic isotope that is combined with […]

REC Group begins mass production of Alpha Series solar panel in Singapore

REC Group, a Norwegian solar energy company, has started mass production of its REC Alpha Series solar panel in Singapore for which it has invested a total of $150 million. The solar energy company also developed a new Industry 4.0 cell fab at the Singaporean solar panel manufacturing plant. The expansion gives an additional 600MW […]

Scroll To Top